Literature DB >> 8993549

The peroxisome proliferator-activated receptors: ligands and activators.

B M Forman1, J Chen, R M Evans.   

Abstract

PPAR alpha and PPAR gamma represent related but distinct members of the nuclear receptor superfamily. PPAR alpha signaling is modulated by long-chain fatty acids, whereas PPAR gamma ligands are potent antidiabetic agents.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993549     DOI： 10.1111/j.1749-6632.1996.tb18621.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  56 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 2.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 3.  The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.

Authors:  H Sadie-Van Gijsen; N J Crowther; F S Hough; W F Ferris
Journal:  Cell Mol Life Sci       Date:  2012-11-21       Impact factor: 9.261

4.  Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.

Authors:  Sarah G Harris; Richard P Phipps
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

5.  Hormone-sensitive lipase-knockout mice maintain high bone density during aging.

Authors:  Wen-Jun Shen; Li-Fen Liu; Shailja Patel; Fredric B Kraemer
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

6.  Nr4a1 is required for fasting-induced down-regulation of Pparγ2 in white adipose tissue.

Authors:  Kalina Duszka; Juliane G Bogner-Strauss; Hubert Hackl; Dietmar Rieder; Claudia Neuhold; Andreas Prokesch; Zlatko Trajanoski; Anne-M Krogsdam
Journal:  Mol Endocrinol       Date:  2012-12-18

7.  PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.

Authors:  Sriram Ramanan; Mitra Kooshki; Weiling Zhao; Fang-Chi Hsu; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2008-09-17       Impact factor: 7.376

8.  Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.

Authors:  Charles Brouillette; Yohan Bossé; Louis Pérusse; Daniel Gaudet; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2004-07-13       Impact factor: 3.172

9.  Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans.

Authors:  V Kaddai; J Jager; T Gonzalez; R Najem-Lendom; S Bonnafous; A Tran; Y Le Marchand-Brustel; P Gual; J-F Tanti; M Cormont
Journal:  Diabetologia       Date:  2009-02-14       Impact factor: 10.122

10.  Initiation of the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH.

Authors:  Mary J Long; M Ram Sairam; Carolyn M Komar
Journal:  Reprod Biol Endocrinol       Date:  2009-12-07       Impact factor: 5.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.